Innate lymphoid cells (ILCs), strategically positioned throughout the body, undergo population declines over time. A solution to counteract this problem is timely mobilization of multipotential progenitors from the bone marrow. It remains unknown what triggers the mobilization of bone marrow ILC progenitors (ILCPs). We report that ILCPs are regulated by the circadian clock to emigrate and generate mature ILCs in the periphery. We found that circadian-clock-defective ILCPs fail to normally emigrate and generate ILCs. We identified circadian-clock-controlled endocrine and cytokine cues that, respectively, regulate the retention and emigration of ILCPs at distinct times of each day. Activation of the stress-hormone-sensing glucocorticoid receptor upregulates CXCR4 on ILCPs for their retention in the bone marrow, while the interleukin-18 (IL-18) and RORα signals upregulate S1PR1 on ILCPs for their mobilization to the periphery. Our findings establish important roles of circadian signals for the homeostatic efflux of bone marrow ILCPs.
Pubmed ID: 38717905 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
Privately held company that develops and produces antibodies, ELISA kits, ChIP kits, proteomic kits, and other related reagents used to study cell signaling pathways that impact human health.
View all literature mentionsTHIS RESOURCE IS NO LONGER IN SERVICE. Documented on May 5,2022.Tool that predicts interactions between transcription factors and their regulated genes from binding motifs. Understanding vertebrate development requires unraveling the cis-regulatory architecture of gene regulation. PRISM provides accurate genome-wide computational predictions of transcription factor binding sites for the human and mouse genomes, and integrates the predictions with GREAT to provide functional biological context. Together, accurate computational binding site prediction and GREAT produce for each transcription factor: 1. putative binding sites, 2. putative target genes, 3. putative biological roles of the transcription factor, and 4. putative cis-regulatory elements through which the factor regulates each target in each functional role.
View all literature mentionsA commercial organization which provides assay technologies to isolate DNA, RNA, and proteins from any biological sample. Assay technologies are then used to make specific target biomolecules, such as the DNA of a specific virus, visible for subsequent analysis.
View all literature mentionsMus musculus with name C57BL/6J from IMSR.
View all literature mentionsThis monoclonal targets IL-13
View all literature mentionsThis monoclonal targets IL-10
View all literature mentionsThis monoclonal targets IL-17A
View all literature mentionsThis monoclonal targets IFN-gamma
View all literature mentionsThis unknown targets IL-22
View all literature mentionsThis monoclonal targets Mouse Laminin alpha 1
View all literature mentionsThis monoclonal targets Glucocorticoid Receptor
View all literature mentionsThis monoclonal targets PLZF
View all literature mentionsThis monoclonal targets Gata-3
View all literature mentionsThis monoclonal targets IL-18
View all literature mentionsThis monoclonal targets CD49d
View all literature mentionsThis monoclonal targets TER-119
View all literature mentionsThis monoclonal targets NK-1.1
View all literature mentionsThis monoclonal targets Ly-6G Ly-6C
View all literature mentionsThis monoclonal targets Mouse RORγt
View all literature mentionsThis monoclonal targets CD45R
View all literature mentionsThis monoclonal targets CD19
View all literature mentionsThis monoclonal targets CD11b
View all literature mentionsThis monoclonal targets CD11c
View all literature mentionsThis monoclonal targets T-bet
View all literature mentionsThis monoclonal targets CD4
View all literature mentionsThis monoclonal targets CD8a
View all literature mentionsThis monoclonal targets CD3epsilon
View all literature mentionsThis monoclonal targets CD186
View all literature mentionsThis monoclonal targets CD29
View all literature mentionsThis recombinant monoclonal targets CD192
View all literature mentionsThis monoclonal targets Ly-6C
View all literature mentionsThis monoclonal targets CD184
View all literature mentionsThis monoclonal targets Mouse EDG-1/S1P1 MAb (Clone 713412)
View all literature mentionsThis monoclonal targets CD28
View all literature mentionsThis monoclonal targets IL-23R
View all literature mentionsThis monoclonal targets CD335
View all literature mentionsThis monoclonal targets CD117
View all literature mentionsThis monoclonal targets CD135
View all literature mentionsThis monoclonal targets CD159a
View all literature mentionsThis monoclonal targets LPAM-1
View all literature mentionsThis monoclonal targets KLRG1
View all literature mentionsThis monoclonal targets Ly-6A/E
View all literature mentionsThis monoclonal targets CD127
View all literature mentionsThis monoclonal targets CD279
View all literature mentionsThis monoclonal targets CD122
View all literature mentionsThis monoclonal targets CD90.2
View all literature mentionsThis monoclonal targets CD45.1
View all literature mentionsThis monoclonal targets CD45.2
View all literature mentionsThis monoclonal targets CD25
View all literature mentionsMus musculus with name B6.129S4(Cg)-Bmal1tm1Weit/J from IMSR.
View all literature mentionsMus musculus with name B6(SJL)-Zbtb16tm1.1(EGFP/cre)Aben/J from IMSR.
View all literature mentionsMus musculus with name B6.129S7-Rag1tm1Mom/J from IMSR.
View all literature mentionsMus musculus with name CByJ.SJL(B6)-Ptprca/J from IMSR.
View all literature mentions